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Abstract 
This report ex.amines the use of Support Vector Machines and Genetic Pro-
gramming Classifiers (GPCs) to distinguish between classes of cancer based on 
gene expression data. The effect of feature selection on classifier accuracy and 
on the convergence time of GPCs is. experimentally investigated, with the goal 
of making classification problems on gene expression data tractable to GPCs. 
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Chapter 1 
Introduction 
Throughout biology today scientists are being deluged in data, and they are 
unable keep up with this constant stream without specialised tools. For this 
reason computational methods and computer software are being developed to 
help biologists cope and ~ome to grips with the quantity of information available 
to them. These methods and their study are part of the expanding field of 
Bioinformatics, also kliown as Computational Biology, and has been vital in 
making sense of all the biological data available. 
Originally this excess of data mainly came from sources. such as DNA and 
protein sequencing, but recently mic:roarray technology has become more com-
mon place. Microarrays are used to detect the expression levels of thousands of 
genes within cells, allowing biologists to extrapolate gene interactions and how 
these genes may regulate one another. The advent of this technology has brought 
to data analysts broad patterns of gene expression simultaneously recorded in 
a single experiment(Foclor 1997). 
Another use of these gene expression data is in the domain of tissue c:lassifi-
cation. Although all cells within an organism contain the same set of genes, not 
all of these are expressed in all tissues and this is an important behaviour for 
tissue differentiation. Therefore, the pattern of genes expressed in a particular 
tissue sample should allow us to categorise the samples site of origin. 
Cancer can arise from the improper expression of genes. such as genes in-. 
volved in cell death ( apoptosis) being switched off, or over expression of genes 
involved in cell proliferation. Thus the pattern of genes expressed by cancerous 
tissue ·will be altered from that of normal tissue and detection of these alter-
ations by machine learning categorisation techniques allow us to classify between 
cancererous and normal tissue. 
A fmther issue is being able to differentiate between cancerous tissue. For 
example, given a cancerous tissue sample, can we determine its tissue of origin? 
.Since the gene expression patterns between normal tissues are different, "\Y~. Qan 
assume that tumours originating from these normal tissues will also exhibit 
1. i --aifferent gene expressionpatterns. Although there are likely to be certain genes 
-- ·· -that· show a commonality in ·their expression· among many tumours. Being 
1 
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able to differentiate between cancerous tissue is useful when a tumour is first 
discovered within a patient, because it is initially unknown whether this tumour 
originated in the tissue it was found in or is a secondary tumour resulting from 
a primary tumour metastasis. 
Microarray data is· often made available to the public online in a manner 
similar to the human genome project. A dataset of 280 human tissue samples 
that under went microarray processing was retrieved from (Ramaswamy 2001). 
These tissue samples were taken from both healthy individuals and from tu-
mours in individuals suffering cancer. The original paper was interested in 
classifying the data using Support Vector Machines (SVMs) within a One Vs. 
All (OVA) scheme. 
~~~ 1'l~_9:i!!l_QL~!!B projeCt is to make use of St!££()~·!.Y~C:.!2!._1\1.9:S:lllg!OJ§J._9.YM~1t?­
machine lE1arning ~fasSifier~To'cTassify·b~-t~efm cancer t)'l~E)S .EtndJl()rl118:1 !:iS§1:te. 
~--s\tl'irs·are-very-gooa·at\Vl'iattlie}' ao~ "oi:it ·a::re·uiii1ltuitive to Novamente, an 
artificial intelligence engine designed to show the emergence of true general 
artificial intelligence. The way SV1v'Is store the classification model prevents 
Novamente from being able to (easily) draw inference from the learning of cancer 
classes. \Ve propose to determine what features of the cancers are rele,;ent via 
SVMs and Recursive Feature Elimination, then use these features in Genetic 
Programming predictors. GE?netic Programming results .in rules much closer 
to the underlyh1g architecture of Novamente, A comparison of the accuracy 
between SVMs and genetic algorithms using the same set of features will be 
made. · 
1.1 Overview 
Further background material is presented in Chapter 2 wh.ere cancer and mi-
croarra.ys are discussed, as well as details on Support Vector Machines and 
Genetic Programming. Chapter 3 specifies the technical details of the exper-
iments carried out for this report, with the results presented in Chapter 4. 
Chapter 5 provides a discussion of some interesting points; and further work to 
be done in the area of classification from gene expression data. Finally, Chapter 
r:;oncludes the report. 
'/\ 0 i) ( 
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Cl1apter 2 
Background 
Currently the diagnosis of cancer involves the interpretation of clinical and 
hist.opathological data with the goal of ultimately placing a tumour into one 
of the currently accepted categories. There are a number difficulties here. ·For 
instance, there is a wide spectrum of cancer morphology and mmiy tum.ours 
are atypical, lacking morphologic features often used in diagnosis (Ramaswamy 
et al. 2001). To this effect there have been calls for mandatory second opinions 
in all surgical pathoiogy cases (Tomaszewski & LiVolsi 1999). 
These difficulties hinder our al)ility to give patients the optimum care pos-
sible as well as increasing the expense of caring for them. Differences between 
tumours classified similarly by doctors may even confound clinical trials for new 
anti-cancer treatments. · 
Molecular diagnostics promise prec:ise objec:tive classification of tumours. 
However, characteristic: molecular markers have yet to be identified for most 
tumour types (Connolly et al. 1997). Gene Expression diagnostics have the 
advantage that expressions of genes with unknown functimis can be monitored. 
Genes important to the development of cancer are potential places to look 
for creating molecular markers. They may encode for altered proteins specific 
to a cancer class and molecular diagnostic markers based on these proteins can 
b d ~-~ e ma e. r '~ \. . 
Ramaswamy\( (2001 )pxplored the possibilty of cr~ating .a.refer~nce database 
of tumour gene expressiOn data for all cmnmon mahgnancws. Tlus could then 
serve as test bed for testing new cancer classification methods. Ramaswamy 
tried several machine learning methods on the initial version of their reference 
database, including k-Nearest Neighbour, \iVeighted Voting and Support Vector 
Machines. They also investigated using unsupervised clustering. 
2.1 Microarrays 
A microarray allows a researcher to view the expression levels of thousands of 
genes simultaneously .at a particular point in time by taking advantage of an 
3 
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intermediary step in the expression of genes. At this step, DNA is transcribed 
into messenger RNA (mRNA) before being transported to ribosomes where it 
is translated into a protein, which carries out the function of the gene. 
In order to construct a microarray, precisely measured quantities of single-
.stranded eDNA (copy DNA) transcribed frommRNA are bound to spots on a 
glass slide. These slides are then rinsed with fluorescently labelled mRNA from 
the cells whose expression levels wish to be observed. The strands of fluorescent 
mRNA that are complementary to those on the slide will bind, and when the 
slide is developed the brightness of individual spots indicate a quantitative mea-
sure of how much of each mRNA strand was present in the cells at the moment 
of sampling. This measure indicates how much the gene is being expi·essed- the 
·more mRNA molecules that are transcribed from a particular gene the more 
protein that can be translated. 
In essence this means a microarray provides a snapshot of all the genes that 
. are of interest and their levels of expression. The collated data from a set 
of microarray experiment form a gene expression matri:z: where each column 
represento; a tissue sample and each column refers to a gene. 
2. 2 N ovan1ente 
No,ramente is an artificial intelligence (AI) engine that has the lofty go.al of gen-
eral artificial intelligence ( GAI), developed by the Artificial General Intelligence 
Research Institute (AGIRI) 1 . Thus, it differs from other AI engines in that it 
will be capable of being applied to any domain and will be able to formulate 
its own goals and beliefs. The creators behind this engine are fully aware. of 
the failed attempts of other similar projects, but believe that the fundamental 
design of the Novamente mind will result in emergent intelligence ( Goertzel et 
al. 2003+). · 
This project does not rely on any of the explicit GAI properties of the 
Novamente engine, so that belief in whether GAI is possible or not will not affect 
Novamente's use as a powerful' machine-learning tool. Novamente combines 
numerous AI paradigms, both symbolic and connectionist views, allowing it to 
exhibit traditional domain-specific AI behavior. 
One of the most promising points about Novamente in relation to bioin-
formatics, is that it can incorporate background knowledge from biological 
databases when datamining. Such behaviour is still in a state of development 
within Novamente, so it was decided to forego using this background knowledge 
during experiments. 
The basic architecture of the Novamente AI engine is similar to a neural 
network in that it is composed of numerous nodes and the relationships be-
tween them. These nodes and relationships can then be acted upon by MindA-
gents that carry out the system dynamics. Some nodes contain instructions for 
carrying out more complicated actions and these instructions are executed by 
MindAgents. 
1 http:/ /www.agiri.org 
4 
Novamente was a progression from a previous but similar engine called \Veb-
mind. Due to cmmnericial reasons the company behind Webmind dissolved, but 
the core developers went on to develop Novamente for AGIRl. Novamente was 
designed from \Vebmind, but significant changes were made made based on the 
teams experience. For example, \Vebmind was programmed in Java, whereas 
Novamente is implemented in C++: 
2. 3 Machine Learning 
The term learning can embody a wide scope of processes. Dictionary definitions 
often emphasize the acquisition of skill and knowledge and the associated cogni-
tive processes. Learning is most often prescribed to living creatures when their 
behaviour changes based on past experience. However, the same term can (and 
is) used to des.cribe machine behaviour when the machine takes into account 
past experience to act in the present. 
~'[A] machine learns whenever it changes its structure, program, or 
data (based on its inputs or in response to external information) in 
such a manner that its expected future performance improves." (Nilsson 
1996) . 
Machine learning, like the term it is named after, also embodies a wide scope 
of processes. Here we a primarily interested in classification. 
2. 3.1 Classification 
Classification is the process of dividing instances into classes according to the 
values of an ii1stance's features. Each sample occupies a point in feature space 
which is a theoretical N-dimensional space where each feature is uniquely as-
signed to an orthoganal axis (Kuravilla et al. 2002). 
Figure 2.1 shows a feature space for samples with two features and hence 
two dimensions. 
Unsupervised Classification 
Unsupetvised classification, otherwise known as clustering, attempts to group 
instances without reference to predetermined classes. This is often based on the 
proximity of the instances within feature space (Eisen et al. 1998). Clustering 
can be useful in identifying subtypes of cancer, and in detecting previously 
unrecognised similarities. 
In order to carry out dustering, a distance matrix must be constructed 
where entry (x, y) is the distance between instances x andy. The entry values 
are determined from a distance metric and therefore choice of this metric can 
affect the outcome of clustering. The distance ·metric· is often the Euclidean 
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Figure 2.1: An example of a two dimensional feature space containing samples 
of three different classes. 
distance2 between points or the related Pearsou correlation which is invariant. 
to scaling. 
Supervised Classification 
Supervised Classification rnakes use of a training set. containing instances for 
which the classes they belong to is known. After processing of this training 
set. a class predictor is created for classifying unlabelled instances (Radmacher 
et. al. 2002). For cancer this involves assignirig the clinically defined tumour 
class to each gene expression profile in the training set. 
2.3.2 Support Vector Machines 
Support Vector Machines (SVMs) are powerful supervised classification systems 
based on a variation of regularization techniqties for ·regression (Vapnik 1998) 
(Evgeniou et al. 2000). They provide extremely good performance in a wide 
range of binary classification domains with computational advantages over their 
cont.enders(Cristianini & Shawe-Taylor 1999). SVMs are a regularization of an 
older machine learning method called the peTceptmn(Rosenblatt 1962) (Minsky 
& Papert 1972). The perceptron tries to find a hyperplane that seperates pos-
itive from negative classes, and in general there may be any number of such 
hyperplanes. SVMs specify that this hyperplane must have the maximal maT-
gin (the distance fro_m the hyperplane to the nearest point). 
2The Euclidean distance equals the square root of the sum of the distances between points 
on each axis. 
6 
The creation of the hyperplane for the SVM is an optimisation problem, 
where the SVM must construct a hyperplane to maximise the distance from the 
hyperplane, TV, and the closest instances to the hyperplane. This distance is 
calculated in N-dimensional euclidean sp~ce, where N corresponds to the num-
ber of features in each instance. 'Il-ainh1g an SVM and finding this hyperplane 
requires s9lving· a convex quadratic problem with as many variables as train-
ing points. Kernels may be employed by SVMs to transform the data so that 
non-linear seperation can be captured. Different kernels or methods of trans-
.formation exist, the simplest being linear which performs no transformation. A 
polynomial kernel allows the SVM to capture any arbitary seperation by finding 
the order-N polynomial that best fits: S®ili1r!yjQ~.iJ]:.~_9J!:ILSsj_p,nl~~n!et_C>c~T?\ (>' \ '1 
The class of an unknown test sample is determined by which side of the 
hyperplane it lies on. It is given the same class as the training samples on the 
side of the hyperplane which it is located on. 
SVMs have been applied to several biological domains, including gene ex-
pressionmi:croarrays (Mukherjee 1999)(Brown et al. 2000) and are particularly 
suited to gene expression based categorisation since they can handle the large 
number of features often produced in this domain. 
For further information on Support Vector Machines, including mathemati-
cal proofs, see either (Vapnik 199?) or (Evgeniou et al. 2000). 
2.3.3 Genetic Progrmnming 
Genetic Classifiers come under the broader term of Evolutionary Algorithms 
(EAs) which was popularised by (Holland 1975) and is inspired by Darwin's 
evolutionary theory (Darwin 1859). 
"[All the fields within evolutimiary computing] share a common con-
ceptual base of simulating the evolution of individual structures via 
processes of selection, mutation, and reproduction. The processes 
depend on the perceived performance of the individual structures as 
defined by an environment." 3 
EAs can be thought of as an optimisation problem, searching through po-
tential solutions to find the optimal one (Michalewicz 1996) 
The population contains initially poor and randomly created solutions to 
the problem. These are then evaluated using a fitness function, with the fittest 
selected and mated to create a new population. To create offspring (problem 
solutions) for the new population, the best solutions of the current population 
~re subjected to crossover recombination. These solutions can be thought of as 
points of a landscape called the solution space, where each point has a certain 
fitness associated with it. Selecting the fittest individuals push these points 
"uphill" to areas of higher fitness (Kauffman 199.5). Mutation can also occur to 
introduce further variation mid prevent over crowding of a solution space. This 
3 The Hitch-Hiker's Guide to Evolutionary Computation (FAQ for cornp.ai.genetic) 
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Figure 2.2: Flow chart of the evolutionary algorithm process. 
also helps avoid a population becoming stuck near local optima and introduces 
attributes that may not have been present in the initial population. 
Recombination and mutation may result in offspring with superior fitness 
over their ancestors. A regime following the often coined term ''survival of the 
fittest" ensures the b~st solutions, or parts of them, progress to the next gener-
ation. Through iterated generations better solutions are repeatedly found and 
those attributes which contribute to a high fitness accumulate. This evolution 
hmvever is bmmded by the ideal solution to the problem, or the global optimum 
in the solution space . 
. Figure 2.2 shows a flow chart of the evolutionary algorithm process. The 
population is initially created, all individuals then have their fitness evaluated 
and then it is compared to the required fitness. If the fitness of the best in-
di-vidual meets this minimum required fitness then the process ends and the 
individual is returned as a result of the evolutionary algorithm. Otherwise the· 
best incliviclual(s) is taken and used to generate a new population which then 
allows the process to repeat: Sometimes the stopping condition is replaced with 
a counter for the number of generations that have passed. 
Sometimes evolutionary process are misunderstood as a purely random search 
through the solution space, which leads to justifiable doubt ove:J: the usefulness 
of evolution. There is obviously random aspects in evolutionary processes, such 
as mutation and the location at which recombination occurs, but the important 
point is that attributes representing high fitness are accumulated over genera-
8 
tions. Offspring are created based on already proven attributes (Dawkins 1996). 
Ultimately, the definition of fitness and the fitness function, whether artificial 
or natural, are important in guiding the progression of evolutionary processes. 
Novamente _implements a classifier system that uses genetic programming 
to create individual solutions (each a function tree) capable of differentiating 
between classes. These are known as Genetic .Programming Classifiers (GPCs). 
Fitness Function 
The fitness function determines how closely a candidate matches the ideal so-
lution. Generally the fitness function is a rank based fitness assignment (Baker 
1985), or a proportion of the average fitness of the population (Goldberg 1989). 
As generations pass, the best solution converges towards the ideal. This is 
reflected in the fitness difference between the fittest candidat8 and the ideal 
solution approaching zero. 
Novamente uses a fitness function based on the number of incorrectly clas-
sified training examples: 
(2.1) .fitness 1 
1 + n 
/~\ (2.~ 
(~~here n is the number of incorrectly classified examples. This limits the 
fitness of a candidate in the range [0, 1), with a fitness of 1 representing the 
ideal solution: a classifier that makes no mistakes in classifying the training 
data. 
Population Size 
The population size is the number of individual solutions present during any 
particular generation. This is usually kept constant over all generations for 
simplicity. If constant population size is maintained, then the number of new 
individuals created during each new generation is dependant on the survival of 
the offspring's parents. 
Some evolutionary methods allow individuals to mate to create new individ- ('( ( 
uals for the next generatibn, before being "killed". ~!hileothersselect a per- (' ' \Jc, · 
centage of individuals with high fitnesses and place them in the next generation, ' i· \ •''' 1 ' ' 
filling the remaining spaces with their offspring( Aliow)parents to survive limits 
the amount of available positions for offspring, or new solutions to the problem, 
and can result in a population being caught on local optima (Kauffman 1995) 
when parents become too similar. Similarity prevents cross-over from creating 
sufficiently unique individuals to explore alternative solutions. However, allow-
ing parents to survive can avoid oscillation of the population's maximum fitness 
whi.ch could lead to a final solution being less fit t~en it could have been. 
Novamente uses a model in which certain randomly selected individuals in 
a subgroup compete and the fittest individual is selected. This is called tourna-
ment selection and is the form of selection we see in nature. For instance,' stags 
9 
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Figure 2.3: Each individual in a population of genetic programming solutions is 
a function tree. The tree's leaf nodes take inputs from the data and can contain 
constants, the rest of the nodes contain operators which recieve input from their 
children nodes. Evaluating a function tree n>.sults in a value at the root node 
(in this cane 0.15). During training this value is compared to the desired value 
in order to calculate the individual's fitness. 
rut to vie for the privilege of mating wi-th a 1wrd of hinds, and the winner gets 
to pass their genes to the following generation. 
Novamente also employs the concept of elitism. This is where the fittest 
individual from a generation is allowed to live on in the next generation. This 
combats possible oscillations in maximum £tness, but prevents being caught in 
local optima as the offspring are free to pmsue alternative solutions. 
Function 'Il·ees 
Each individual in a genetic progi·amming system represents a binary function 
tr-ee which is much like the trees created by .some rule-based classification sys-
tems. Each node in the tree can contain :an operator from a predetermined 
set (such as multiply, add, maximum, :milllimum etc.), recieve an input from a 
specific feature in incoming examples, or be a constant value (see Figure 2.3). 
Traditionally cross-over recombination ;;mel nmtation have been defined on a 
linear chromosome (clue to the biological origins of these processes), and it is not 
immediately clear how these procedure wo:uld occur on a tree. Tree cross-over 
is facilitated by randomly selecting a node within the one tree and exchanging 
it, and its children nodes, with a randomly selected node in another tree. 
A mutation on a tree selects a random :node and either changes the operator, 
the feature to take input from, or its yalue if it is a constm1t. 
\Vhen using genetic prograi11s for da.ssification, each function tree created 
represents a class that it is being evolved to l'eeognise. A tree is evaluated against 
an example by setting all of its input nodes to the values of the specified features 
10 
in the example. Each node then performs its operation, taking input from its 
children. If the children also have operations associated with them then they are 
first evaluated. This occurs until nodes with either feature values or constants 
are reached (these are always leaf nodes), then the values are processed by 
their parents and the results propagate up through the tree until ultimately the 
root node is evaluated. The value that the root node outputs by performing its 
operation is the final output of the tree (unless the entire tree only consists of the 
root node, in which case either the direct value of a feature or a constant value 
is returned). This output is limited to the range [0 ... 1], with 1 representing a 
positive classification and 0 a negative one. 
Usually the depth of the trees are predetermined, and this affects the number 
of feature inputs that can be incorporated into the classifier. For example, if 
we have examples with 500 features, then we would need at least 500 leaf nodes 
in the tree. Since we are dealing with binary trees the minimum depth can be 
expressed as: 
depth . logN = cezl( log 2 ) (2.3) 
where N is the nunlber of features, and the function ceil(x) returns the first 
integer greater than a:. For 500 fe~tures this works out to a depth of 9. 
The tree depth has a major impact on training speed since each tree needs 
to be evaluated for its fitness and each increase in depth doubles the number of 
leaf nodes. This increases the number of operations needed for tree evualation 
and the relationship can be seen in Figure 2.4 
oper.ations (2.4) 
Equation 2.4 determines the number of operations a function tree performs, 
where d is the depth of the tree. The series starts at 2d-2 because the first depth 
is represented by 2° al'J.d the 2d-l leaf nodes are inputs rather than operators. 
Equation 2.4 simplifies to 
operations (2.5) 
Convergence (\~1 .. ~) 
Convergence is ~;~;ess of an individual's fitness reaching its highest possible 
value given the constraints of the function trees. Often the optimal solution and 
its associated fitness is unknown however. If the highest fitness for a population 
remains stable for large number of generations it is assumed to be the optimal 
·solution. However, it nw.y only be a local optim.a, preventing the population 
from exploring alternative possibilities. 
Genetic program classifiers are adversely aff~cted by excessive irrelevent fea-
tures, because a mutation on an input node is less likely to attach it to a useful 
11 
Number of operations required to evaulate a function tree !Jf depth d 
9000 
. 8000 
7000 
6000 
"' 5000 c 0 
~ 
Q) 
c_ 4000 0 
3000 
2000 
iOOO 
0 
0 2 4 6 10 12 14. 
depth (d) 
Figure 2.4: The number of operations required to evaulate a function tree of 
depth d. 
feature. This increases the number if mutations required before a relevent fea-
ture is seleded and therefore the number of generations to train a classifier to 
a certain accuracy also increases. 
This il,a'lmportant problem when dealing with gene expression data, be-
cause each sample often contains thousands of features, most of which are not 
associated ·with the classes that are trying to be differentiated. Feature selec-
tion can reduce the amount of irrelevent. features and reduce the amount of time 
required to train a genetic program classifier to a tractable amount. 
2.3.4 Feature Selection 
,,,~, 
Feature selection is the process of rembving features from a dataset while trying 
to maintain the highest possible level of classification accuracy. There are several 
reasons to conduct such a procesil, one of which was discussed in relation to 
;/ 
GPCs in section 2.3.3. Anothel';1s in an attempt to overcome over'fitting. 
Overfitting occurs when t1\e/~1mnber of features is large while the number 
of training examples is comparatively small, and produces classifiers that can 
accurately classify the training examples, but perform poorly on real data. It 
is essentially the classifier matching the training data too well, such that will 
not recognif!e examples that have· slightly differences. Ove.rfitting car1 be over-
come. by either using the training techinique of regularisation (Vapnik 1998), 
or reducing the dimensionality of the data. The latter of which is used in this 
project. 
12 
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To reduce the dimensionality of the data, we have several options. Firstly 
we can pmject the features onto a few principal dimensions. In this way new 
features are obtained that are linear combinations of original features (Duda 
& Hart 1973). This method however has the disadvantage that none of the 
original features are discarded. Secondly, we can employ one of a number of 
pruning methods which eliminate features from the data set. Pruning has prac-
tical importance to diagnostic tests for cancer (or other diseases) as it improves 
cost effectiveness of searching for marker sites, and eases verification of gene 
relevence. Pruning is what this report refers to when feature selection is Inen-
tioned. See (Kohavi & Jol11y n.d. )) for a review of different feature selection 
methods. \ _// . 
If we have a s1nallnumber of features, it is conceivable for us to exhau:=;tively 
search through all subsets of features and evaluate each mode{bsed op selection 
criterion (Kearns et al. 1997). Tl1is is of course impractical-for gene expres-
sion datasets with thousands of features clue to the combinatorial explosion of 
subsets. 
Feature Selection by Correlation Coefficient 
Features can be invidiclually selected based on how much they contribute to the 
. sepei:a}l'on of classes can produce ·a simple feature ranking. Golub et al. used a 
\..:._cmfefation coefficient defined as: 
(J'Li ( +) - J'Li (-)) 
(o-i(+) + O"i(-)) 
.n !r \ 
(2.6) 
where J'Li and O"i are the mean and standard deviation of the gene expression 
values of gene i for all instances of the positive ( +) and negative (-) classes, 
i = l..n. This results in large positive values for genes correlated with the 
positive class and large negative values for those correlated with the negative 
class. Golub et al. used this coefficient to select equal amounts of positive and 
negatively correlated genes during selection. Since then the absolute value of 
wi has been used as a ranking criterion (Furey et al. 2000) and Pavlidis et al. 
have used a similar coefficient: 
(J'Li ( +) - 1-li (-)) 2 
(o-i(+)2 + O"i(-)2) (2.7) 
These selection methods eliminate noisy features but can result in redundant 
genes being kept, ansJ.· are unable to recognise compler~1entary features that 
individually do not seperate }1le data well. 
(~j .. ? 
· Recursive Feature Elimination 
Recursive Feature Eli~11ination (RFE) is a computationally efficient greedy fea-
ture selection algorithm introduced by Guyon et al,.. It recursively removes 
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features with the smallest absolute weights in a hyperplane produced by an 
SVM. 
The RFE algorithm is: 
1. Train(an})VM to distinguish between classes using all remaining features. 
2. Calculate the ranking criterion, wf, for each feature. 'Where wf is the 
square of the hyperplane component that feature ·i contributes. 
3. Remove the feature with lowest ranking criterion. 
4. Continue to 1 unless only the desired number of genes remain. 
RFE allows more. than one feature to be removed per iteration, although 
this may lead to a subset of features which is not optimal. Unlike correlation 
coefficients, RFE recognises gene interactions and can remove redundant genes 
(Guyon et al. 2002). RFE does require an SVM to be trained for every iteration 
though. 
2.3.5 One Vs. All 
The problem of combining b~n.ary classifiers has been studied in the computer 
sGience literature (Allwein 2000) (Guruswami & Sahai Hl99) from a theoreti-
cal and empirical perspective. However, the literature is inconclusive, and the 
best method for combining binary classifiers for any particular problem is open 
(Ramaswamy 2001). 
____ ];'<)__aJlow bh~l{l(Y cla.~ifiers to handle multiple classes there are two major 
approaches, One Verses :All (OVA) and All Pairs (AP). Using the One vs. All 
methodology it is possilie to combine multiple binary classifiers into a multi-
class classifier. A separate binary classifier is trained for each class by treating 
exemplars belonging to the class as positive exemplars and all others as neg-
ative. ·when classifying a new example the winning class is the one with the 
largest margin. How this margin is created is dependant on the classification 
method and can also be thought of as a signed confidence measure. 
For N classes we haveN binary OVA classifiers, (h ... fN ), each of which 
output a margin value. The class is then determined by: 
class (2.8) 
For any new instance being classified through the OVA approach we can 
assign a confidence measure to its classification. This is determined by the 
difference from the margin, fi, of the selected class to the next highest margin 
of another class. 
SVM 
For SVMs the margin value of a classification has· direct meaning. This margin 
is the distance of a sample to the s{reratiiigJwperplane between the two classes. ~. \'')' 
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Figure 2.5: The margins of a 14 binary classifiers that together form an OVA 
classifier from this report. These margins are for a Breast cancer sample. 
An example of an OVA SVM classifier is shown in figure 2.5. This figure 
shows the Breast; classifier strongly matching an example; and due to the large 
difference betwe n it and the next highest margin it is match of strong confi-
dence. 
' Genetic Al~orithms 
The output frpm the,Novamente genetic programming classifier is a value in the 
range [0 .. .f1f. \i'.,TheiJ 1 reflects a strong match and 0 a rejection. This value 
can be tak~'ltdirectly and used as the margin. 
I) J) .\( i' 
.1) cv· \' '· · ·· 
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Chapter 3 
Technical. Details 
3.1 Dataset 
The dataset consisted of 218 tumor samples, spanning 14 common tumor classes 
(see A.2). Each sample had 16063 gei1e expression values associated with it. 
- Rmi.1'aswamy divided 144 of these samples into a trainii1g set and 54 into a 
t~st set \including 8 which were tr. m~netastasic samples). Th~ 1:e~t were poorly 
dtfferentrated and added to a s pera~e test set. The same drvtswn of tumour 
samples is used in this study, ho 'B"\~fi the poorly differentiated test set was not 
used. 
See (Ramaswamy 2001) for a detailed methodology of how the microarrays 
used in this study were constructed, irtduding the sources of the tissue samples. 
3.1.1 Preprocessing 
Preprocessing operations are those that occur to a dataset prior to more detailed 
analysis in order to make it more suited to the aualysis methods or research ques-
tion. Th~ three preprocessing operations often used in application to microarray 
data are (Holland 197.5): 
• Thresholds - Thresholds are upp~r and lower numerical limits applied to 
outlier values. Negative expression values are thought to be unreliable and 
cannot easily be understood in physiological terms (Mutch et al. 2001). 
To overcome these negative values low expression values are rounded to 
an arbitary lower limit of between 20 and 100 expression units. 
• Filters - filte~s remove certain genes from a dataset. This can help to 
eliminate noise and reduce the size of the dataset, as ·well as inhibit over-
fitting (see section 2.3.4). Filters are also used to limit genes based on 
some form of biological criterion, such as which chromosome they lie on. 
• Transformations- transformations globally change a dataset with math-
ematical operations. An example is the logarithmic transform, which is 
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especially useful when applied to microarray data because variance has 
been observed to be proportional to signal intensity. Gene expression val-
ues at high signal intensities are less reproduca.ble than lower intensities 
(Nadon & Shoemaker 2002) 
All the gene expression values in the d'ataset used in this report had a thresh-
old of 20· to 16000 applied, before being logarithmicly transformed. Each feature 
(gene) was then linearly mapped to the range [0 .. 1] with the minimum at 0 and 
the maximum at 1. 
3.2 Imple1nentations 
3.2.1 Support Vector Machine 
A modified version of SVMTorch (Collobert & Bengio 2001) was used to generate 
SVM models. The modifications1 enabled recursive feature elimination to be 
carried out. 
(Ramaswan:J:)' 2001) showed that a linear kernel could create a hyperplane 
able to fully s~er~te the training data when all16063 features were incorporated 
.into the modei. (Ramaswamy 2001) justified the choice of a linear kernel by the 
dataset consisting of relatively few data points in a large number of dimensions. 
Similarly in this report, a linear SVM was tised. 
A Lagrange multipliers limit value of 100 was specified and an epsilon value 
of 0 .. 5 used for tolerance2• 
3.2.2 Feature Selection 
The least significant 60% of features were removed at each iteration of RFE. 
RFE was performed within the modified version SVMTorch for SVM Clas-
sifiers. At the end of an RFE run in SVMTorch a smmnary of the features 
removed at each step was created. This summary was then passed to a purpose 
built Java application to create data files for classification by GPC3 . Each file 
represented a step in the RFE process. 
Each binary classifier in an OVA scheme is independant of the others, so 
in RFE they select the features which are most f)ignificant in that particular 
class versus all others. This creates a seperate hierarchy of feature sets for each 
binary classifier. 
For the feature selection approach using a correllation coefficient, the defi-
nition by (Pavlidis et al. n.d.) was chosen: 
(/Li ( +) - ILi (-) ) 2 
(O'i(+)2 + O'j(-_)2) 
1 Partly implemented by Bernardo P. R. Carvalho of Biomind (bernardo@vettatech.com) 
2 As suggested by the SVMTorch manual. 
3 Framework code for parsing the WICGR RES file format supplied by Lucio de Souza 
Coelho (lucio@vettatech.com) 
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Data files were created using this measure for the corellation coefficient and 
a similar Java application to that used for RFE data file creation. The same 
number of features as for each iteration of RFE (renwving the least significant· 
60%) were selected for each file. 
The correllation coefficient for each feature changes with the each binary 
classifier within an OVA group, because each cl~ss alters the mean and standard 
deviation of.the positive and negative groups. Therefore, feature selection by 
corellation coefficient, like RFE, results in a hierarchy of feature sets for each 
binary classifier within an OVA scheme. 
3.2.3 Genetic Progran1 Classifier 
The code for the GPC implemented within Novamente \:Vas altered to allow invi-
cliclual OVA classifiers to each use their own hierarchy offeatures as determined 
b}' feature selection. · 
Each GPC was created with a population of 50 individuals, and a mutation 
rate of 0.005. Elitism was disabled, with new generations created from the 
winners of tournam.ent selection. 
The de]:ith of trees within the population was set by the following formula: 
depth 
3.3 Platforn1 
logN 
ce·il ( -
1 2 ) + 1 og (3.2) 
" All experiments were conducted in Linux on . .eitl~1'~-\\rorkstations with either 
Athlon XP1800+ oi· Intel Pentium 4 (2.40GHz) CP'Bs, and .512Mb RAM. 
3.4 Testing Pipeline 
The following steps outline the procedure for the experiments: 
• Preprocess raw microarray data and save into SVMTorch format. 
• Run SVMTorch with RFE for each OVA classifier saving summaries and 
classifying test data at each iteration. 
• Preprocess raw microarray data again, but take into account RFE sum-
mary and save into Novamente format. 
• Evolve GPCs. within Novmi1ente, on each iteration of RFE data. 
• Preprocess raw microarray data again, calculating corellation coefficients 
to create feature subsets. Save subsets into Nova.mente .format. 
• Evolve GPCs within Novamente, on each iteration of corellation coeffiecient 
select<?d data. 
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Chapter 4 
Experimental Results 
4.1 Hypothesis 
Two hypothesis were investigated to test the feature selection with GPCs. 
Hypothesis 1 RFE feature selection will give higher accnracy classification in 
GPCs. 
Hyppthesis 2 Feature selection will reduce conveTyence time of GPCs. 
! 
4.2 Accuracy of Suppo~_t Vector Machines 
This section reports the results· of~M )curacy with feature selection and 
compares them with the original s~,c~d~by (Ramaswamy 2001). vVhile not di-
rectly related to the hypotheses, the results from these experiments questions 
specific details of the original study's methodology. 
Each OVA SVM classifier (14 individual binary classifiers) took an amount 
of time proportional to the number of features being used. In general however, 
they took from 10-30 minutes each to create. 
Figure 4.1 shows the effect ofRFE on SVM classification accuracy when the 
data is used raw without preprocessing and when preprocessing is used. The 
accuracy of SVMs applied to preprocessed data is generally better than on raw 
data. 
Comparing tlie curves to the graph presented by (Ramaswamy 2001) (Figure 
4.2) it suggests that the original study did not use data preprocessing. Their 
report states that preprocessing was used but was ambiguous as to whether it 
was specifically used with RFE. 
The effect of sub-optimal feature selection due to removing large sets of 
features every iteration can be seen between Figures 4.2 and 4.1. The results 
of this study show much lower accuracy than Ramaswamy at low amounts of 
features. This is likely due to Ramaswamy removing the least significant 10% 
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Figure 4.1: The effect on cl:assification accuracy with increasing numbers of · 
features (N) 
of features rather than the 40% removed in this study. Removing more features 
at every iteration, results in less optimal subsets being created. 
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Figure 4.2: Classification accuracy of SVMs in study by Ramaswamy, also shown 
are results fork Nearest Neighbour and Weighted Voting classifiers. Graph from 
http://www.pnas.org/cgi/content/full/98/26/15149 
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4.3 Genetic Progra1n Classifiers 
I ·, 
Here we examinE\the the validity of the two hypotheses from Section 4.1. 
4.3.1 Accuracy 
The feature selection method that results in the best GPC accuracy depends on 
the number of features present at a particular iteration, as shown in Figure 4. 3. 
At low numbers of features ( < 20), the corellation co~fficient selection method 
results in the best accuracy. vVhereas 'higher numbers of features (> 20) give 
better accuraey when selected with RFE. 
This is possibly clue to depth of tree being limited at lower feature numbers 
preventing complex rules evolving which are needed for the combined signifi-
cance of RFE selected features to emerge. 
Thus, Hypothesis 1 is correct for n:10re than twenty features present, but for 
less than this, the corellation coefficient feature selection method is best. This 
validation is made with the reservation that shallow trees at a low number of 
features may be preventing the significance of RFE selected genes being utilised. 
4.3.2 Convergence 
To investigate the convergence of GPCs, the accuracy of individual binary clas-
sifiers within an OVA group were analysed, as well as the average fitness for· 
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OVA groups. 
Between binary classifiers in an OVA group we often observe large jumps 
in fitness (see Figure 4.4. These probably represent a significant gene, along 
with its relation to the class, being included in the GPC function trees. For 
particular classes, markedly sharp increases in fitness occured. These "jumps" 
in fitness may indicate a })articular gene being found that is heavily involved in 
the development of that cancer type. The most marked jmnps were observed in 
Colorectal, and also to a lesser extent in Bladder. 
There is variation in fitness levels for the various GPC binary classifiers (at}d 
consequently their ability to distinguish between cancer types), which may give 
an idea of the relative difficulty of distinguishing cancer classes. For example, 
Leukemia and Lymphoma both have relative low fitness, whereas Renal cancer 
and Melanoma have high fitnesses. This may indicate that that Renal and 
Melanoma have distinct patterns that classifiers can pick up, while the patterns 
for Leukemia and Lymphoma may be more subtle. 
Another observed plte.nomenom is that some classes reach a "plataeu", or 
converge, faster than others .. The Leukemia, Uterus, and Bladder classes show 
this behaviour. 
The sharp peaks that Cliccur in the binary clasifier fitnesses indicate that the 
most· fit individual was not involved in tournament selection and hence did not 
continue to the next generation. 
Figure 4.5 presents the fitness of an OVA ·classifier based on the average 
fitness across all its binmy classifiers. Fast convergence is observed for a low 
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number of features, and this supports hypothesis 2. 
However,· this may be a result of varying the tree depth of GPCs. More 
complex rules can be created by deeper trees, but this complexity will take 
longer to emerge through evolutionary selection. Convergence to an optimal 
value wouid be quicker for shallow trees. . 
The results presented so far don't indicate whether an ideal solution is 
reached. 'To investigate the timing required to search the solution space for 
an ideal classifier, a OVA GPC was run for 10000 generations with a eventual 
accuracy of .51.9% on the test set. The rate of fitness increase slows (see Figure 
4.6) and seems to approach an asymtope which preslm1ably represents the ideal 
solution. The fitness does not reach a constant value in the number of gener-
atim~s observed: There is also a sharp increase just before 9000 generations, 
indicating that fundamental changes are still being made late in the process, 
therefore it hasn't reached optilnal solution despite taking over 60 hours to 
execute. 
4.4 S.elected Features 
Table 4.1 displays the five most significant RFE selected genes, based on .their 
contributions to the SVM hyperplane. 
It should be noted that many of the genes appear more than once. Specif-
ically hunLalu_at (and hum_alu_at-2) and L06499_at, the latter being a Ribo-
2.5 
Table 4.1: The five most significant genes for each cancer class as determined 
by RFE. 
Cancer Class RFE selected genes 
Blaclclder 
Breast 
L06499_at 
AA422123.Lat 
Z12962_at 
L06499_at 
U57847 _s_at. 
M62895~s_at 
CNS hunLahLat-2 
AA422123_f_at 
AFFX-HSAC07 /X0035L3_at 
Colorectal hum_alu_at-2 
U.5784 7 ..s.:.at 
AFFX-HSAC07 /X003.5L3_at 
Leukemia hunLalu_at-2 
L06499_at 
U.5784 7 _s_at 
Lung hum_alu_at-2 
L06499_at 
X573.5l..s_at 
Lymphoma AFFX-HSAC07 /XOQ3.51JvLat-2 
AFFX-HSAC07 /X003.5L5_at~2 
AFFX-HUMGAPDH/M33197 _.S_at-2 
Melanoma hum_altLat-2 
L06499_at 
Z12962_at 
Mesothelioma M17885_at 
L06499_at 
HG3214-HT339L.at 
Ovary . hum_ahLat-2 
X5735l..s_at 
AA422123.Lat 
Pancreas L06499_at 
M1788.5_at 
AFFX-HSAC07 /X00351 J\Lat-2 
Prostate hunLahLat-2 
L06499_at 
U57847 __s_at 
Renal V00594_s_at 
hunLaltLat-2 
. AFFX-HSAC07 /X0035L3_at 
Uterus __ Adeno hum_ahLat-2 
L06499_at 
U.5784 7 __s_at 
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M6289.5..s_at 
D7920.5...a,t 
Z12962_at 
X16869..s_at 
X16869_s_at 
AFFX-HSAC07 /X0035L3_at-2 
hunLahLat 
AFFX-HSAC07 /X0035L3_at-2 
hmiLahLat 
M62895_s_at 
lmnLahLat 
1116289.5..s_at 
AFFX-HSAC07 /X003.51J'vLat 
AFFX-HSAC07 /X003.5L5_at 
hunLahLat 
M62895..s_at 
X17206_at 
X69150_at 
hunLalu_at 
M62895..s_at 
X17206_at 
U14973_at 
hunLahLat 
M62895..s_at 
hunLahLat 
AFFX-HSAC07 /X003.5L3_at-2 
hunLahLat 
M6289.5..s_at 
Table 4:2: Description of the genes found significant by RFE. 
Gene nmne 
L06499_at 
M6289.5~'Lat 
AA422123Lat 
D79205_at 
Z12962_at 
U.57847 _s_at 
X16869_s_at 
AFFX-HSAC07 /X00351_3_at-2 
AFFX-HSAC07 /X0035L3_at 
htmLalu_at-2 
hunLahLat 
X5 73.51 _s_at 
AFFX-HSAC07 /X00351J\Lat-2 
AFFX-HSAC07 /X00351J\Lat 
AFFX-HSAC07 /X0035L5_at-2 
AFFX-HSAC07 /X003.5L5_at. 
AFFX-HUMGAPDH/M33197 _.5_at-2 
M1788.5_at 
X17206_at 
X69150_at 
HG3214-HT339Lat 
U14973_at 
V00.594_s_at 
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Description 
RPL37 A Ribosomal Protein L37 A 
Annexin II (lipocortin II) pseudogene 2 
zv26h12.r1 Soares NhHMPu 81 Homo sapiens 
eDNA done 754823 5' similar to contains Alu repetitive 
element; mRNA sequence (from GehBank) 
Ribosomal protein L39 . 
EEF1A1 Translation eolongaticin factor 1-alpha-1 
Ribosomal protein 827 (metallopanstimulin 1) 
Eukaryotic translation elong;ation factor 1-alpha-1 
nbne 
RPS3 Ribosomal protein 83 
none 
none 
Glyceraldehyde-3-phosphate dehydrogenase 
RPLPO Ribosomal protein, large, PO 
Ribosomal protein L26 
Ribosomal protein 818 
Metallopanstinmlin 1 
Ribosomal Protein 829 
Metallothionein isoform 2 
somal protein. Indeed, it seems that a majority of the selected genes have an 
association with the Ribosome (Table 4.2). The Ribosome is a cellular organelle 
predominantly involved in protein synthesis from mRNA. This process is called 
translation, and two genes (X16869_s_at and Z19262~at) involved in translation 
are also present in our set of RFE selected gene·s. · 
Of particular interest are the four sequences of unknown function belonging 
which were determined to significant in determining Lymphoma. These could 
be further researched in an attempt to discover more about their function in 
relation with Lymphoma. 
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Chapter 5 
Discussion 
''\f;.,' The results for convergence are likely to be influeu~e y the depth of trees used 
in creating the GPCs. The varying tree depths are ; ecessary to allow the GPC 
to take into consideration all of the features ifit needs to .. To investigate this, 
the experiments should be repeated with a constant tree depth. This depth 
') should be large enough to accomodate all the features of the largest feature 
subset used. 
The tim~ taken for training GPCs is much longer than SVMs. This is due 
to two faCtors, the number of generations and tree depth, both of which need 
to be large in order to get useful classification. The time taken will be partly 
influenced by Novamente using processor time to maintain its system and per-
form MindAgent activities. Although SVMs are much quicker, GPCs result in 
a decision tree that Novamente can absorb. 
It was also realised that the absence of evolutionary elitism was likely to be 
slowing the speed at which GPC fitness increas~s, since fit solutions can be lost 
through random picking of individuals to compete in tournament selection. 
5.1 Further Work 
Alot more work presents itself in the domain of machine learning applied to 
classification of gene expression data. This is reflected by the large nunl.ber of 
related articles currently being published in the literature. 
Areas of particular interest to this study follow. 
5.1.1 Rejection calls 
As a natural consequence of using an OVA methodology, a measure of confidence 
for any particular classification can be made. 
This is clone by finding the difference between the two highest margin values 
of the OVA binary classifiers. This difference can be thought of the confidence 
of classification. 
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Table .5.1: Rercursive Feature Selection with exhaustive search and model se-
lection (RFEX) compared to plain Recursive Feature Selection (RFE) 
RFEX RFE I 
Class #Features Accuracy #Features Accuracy 
Leukemia 2 100% 64 98% 
Colon 4 98% 4 86% 
If machine learning methods are used as a diagnosis tool for oncologists, then 
it would be useful to have a threshold of confidence. \;\,There any classification 
with a confidence less than this threshold is rejected, the oncologist could then 
either redo the gene expression sample or fall back to traditional methods of 
diagnosis. 
5.1.2 Alternatives to GPC 
Although the use of genetic algorithms to classify cancer based on gene expres-
sion is particularly poignant; GPCs are slow. Since the motivation for using 
GPCs was to create a classifier in a form Novamente can absorb and use with 
the rest of its system, other methods of creating classifiers may be investigated. 
Rule induction methods generalise the training set into rules that can be 
used to classify new examples, which make them ideal alternatives to GPCs. 
In particular, ID3 (Quinlan 1986) is a rule-based method that reduces a set of 
training examples to a decision tree. 
The decision tree of ID3 is produced in a top-down fashion. Beginning at the 
root node, attributes are chosen to discriminate between classes with each value 
of the attribute producing a subnode. ID3 continues choosing attributes to dis-
criminate on at each node until all the examples that node have the same class. 
A commercial version of ID3 called 04.5 (Quinlan 1993) supports continuous 
value domains (which are produced by microarrays), by partitioning the range 
of possible values. C4.5 also includes tree pruning which prevents overfitting 
·.and could thus perform a similar function to feature selection. 
5.1.3 Feature Selection Methods 
There are many methods of selecting features from within a dataset, and these 
.may result in selected features that are better for classification by GPCs. 
One such method that is based on RFE combined with an exhaustive search 
of feature combinations along with model selection (Guyon et al. 2001). They 
report that it eliminates gene redundancy, and yields better and more complex 
gene subsets. Table 5.1. shows the number of genes selected by this method 
and their accuracy in classification of cancer types based on gene expression. 
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5.1.4 Gene Clusters 
Clustering is a form of unsupervised learning that where it is assumed the classes 
of samples are initially unknown. This technique could be useful for grouping 
similar genes, and for discovering sub-groups within a cancer class. 
One method. of clustering is the Self Organasing Map (SOM), where one 
randomly chooses the geometry of a grid (e.g., a 2 x 4 grid) and maps it into 
theN-dimensional feature space. Initially the features are randomly mapped to 
the grid but during training the mapping is iteratively adjusted to better reflect 
the structure of the data (Eisen et al. 1998). 
5.1.5 Regulatory Network Inference 
Microarrays give a glimpse of the expression levels of thousands of genes, and can 
be considered as the state of a system or network as overviewed by (Pitt 2003). 
As long as we have a time series of expression levels it is possible to try and infer 
a network of how the genes involved interact. Some may promote other genes, 
while others inhibit them. This is known as an "inverse problem" where the 
dynamics of a systeni are trying to be elucidated from data (Crutchfield 1989). 
Regulatory network inference (RNI) entails working out which genes repress 
one another and how they can cascade and cause chain reactions. For example, 
if gene .A is being expressed, what effect is that likely to have on gene B's 
expression in the future? Often these networks are incredibly complex, especially 
when they involve thousands of genes. 
The Biomind LLC (Limited Liability Corporation), whom use Novamente as 
a tool to analyse biological data, have to some extent already investigated using 
Novamente for RNI (Biomind 2003). It has not been compared to other methods 
of RNI yet, and this is prin1arily due to other methods not being tested on real 
data. In order to test' how accurate a method is, one has to know the underlying 
network to com.pare to the one the method generates. Currently no real data of 
such genetic regulatory networks exist, and so networks are randomly generated 
and simulated to create output similar to that of a microarray. 
It should be noted that RNI is an extension of trying to predicting values 
based on the past behaviour of a gene's expression. As any network that is 
inferred should have prediction power, as well as a host of other characteris~ics 
as outlined by (Wessels et al. 2001). 
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Chapter 6 
Conclusio11. 
This study has investigated using feature selection on gene. expression data in 
order to make the use of Genetic Programming Classifiers (GPCs) feasible. 
The results presented suggest that feature selection using coefficient corellation 
ranking is best for reducing the munber of features to small number ( < 20) of 
features. For greater numbers. of features Recursive Feature Elimination via the 
use of Support Vector Machines is preferential as it gives higher accuracy. 
The accuracy given by GPCs is not sUfficient for practical use in the diag-
nosis of patients, but may still suggest relationships arnoung genes that may 
interesting to study further. An alternative method for creating structures for 
Novamente to reason may be sought by using ID3 to create decision trees. 
The effect of feature selection on the convergence titne was also examined. 
The conclusion being drawn that a smaller number features means a plateau of 
fitness values is reached faster than with a large number. of features. 
Both of the conclusions of this report are dependant on the depth of GPC 
function trees increasing with the number of features. Since it is likely that 
this on its own would also give the observed results, it is suggested that further 
investigation be pursued. 
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Appendix A 
Dataset 
The dataset used in this report is available for public download from http: I i 
www-genome . wi. mit . edu/MPR/GCM. html. A list of samples within the ti'aining 
and test datasets is displayed in Tables A.1 and A.2. · 
A.l Training Sa1nples 
Class 
Breast 
Prostate 
Lung 
Sample Name 
mBRT1 (8697) 
mBRT2 (9078) 
95 I 029 
94 I 15.5 
92 I 078 
9912c068 CC 
93 I 250 
94 I 159 
94 I 052 
95 I 249 
LocalCaP1T 
LocalCaP10T 
p 0025 
p 0030 
p 0033 
p 0036 
Pathology 
Adenocarcinoma, Invasive Lobular 
Adenocarcinoma, Invasive Lobular 
Adenocarcinoma 
Adenocarcinoma, Moderately to Poorly Differentiated 
Adenocarcinoma 
Infiltrating ductal, Moderately Diffetentiated 
Mucinous Adenocarcinoma, Moderately to Poorly Differentiated 
Mucinous Adenocarcinoma 
Adenocarcinoma, High Grade 
Adenocarcinoma, High Grade 
Ad.enocarcjno~1a 
Adenocarcinoma 
Adenocarcinoma 
Adenocarcinoma 
Adenocarcinoma 
Adenocarcinoma 
004 B Adenocarcinoma 
009 C Adenocarcinoma 
93 I 226 Adenocarcinoma 
93 I 146 Adehocarcinoma 
HCTN LUT1 (18702 A1F) Adenocarcinoma, Poorly Differentiated 
HCTN LUT4 (18870 A1C) Adenocarcinoma, Moderate)y to Poorly Differentiated 
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Colo rectal 
Lymphoma 
Bladder 
Melanoma 
Uterus 
94 I 196 
H 20387 
mCRTl (8936) 
mCRT2 (9752) 
95 I 057 
HCTN CRT1 (18851 AlB) 
0001c038 CC 
0001c040 CC 
9912c055 CC 
HCTN 1'9339 
LB_CELL_S93_20626_Y 
L.:.B_CELL_S98_8825_Y 
L_B_CELLS93_04233_Y 
LB_CELL_S94_17150..R 
LJ3_CELL_S98_12569..R 
L_B_CELL_898_124.53..R 
L_B_CELL_S98_17557 ..R 
LJ3_CELL_S94_22323_G 
FSCC_898_11020 
FSCC_898:.:10416 
FSCC_898_5894 
FSCC_898_14359 
FSCC_893_13188 
FSCC_893_20082 
FSCC_893_14386 
FSCC_893_23356 
11520 
9858 
94 I 229 
07-B 003E 
B_OOOl 
B_0002 
B_0003 
B_0004 
94 I 149 
94 I 191 
0-9652 
93 I 262 
96 I 166 
11337 
MGH 10427 
MGH 11511· 
92 I 073 
4203 
34 
Adenocarcinoma 
Adenocarcinoma, Moderately to Poorly Differentiated 
Adenocarcinoma, Moderately Differentiated 
Adenocarcinoma 
Adenocarcinoma 
Adenocarcinoma, :tv!oderately Differentiated 
Adenocarcii10ma, Moderately to Poorly Differentiated 
Adenocarcinoma 
Adenocarcinoma, Moderately to Poorly Differentiated 
Adenocarcinoma, Well Differentiated 
Lymphoma, Large B-cell 
{,ymphoma, Large B-cell 
Lymphoma, Large B-cell 
Lymphoma, Large B-cell 
Lymphoma, Large B-cell 
Lymphoma, Large B-cell 
Lymphoma, Large B-cell 
Lymphoma, Large B-cell 
Lymphoma, Follicular 
Lymphoma, Follicular 
Lymphoma, Follicular 
Lymphoma, Follicular· 
Lymphoma, Follicular 
Lymphoma, Follicular 
Lymphoma, Follicular 
Lymphoma, Follicular 
Transitional Cell Carcinoma, 
Granular and Squamous Differentiation 
Transitional Cell Carcinoma, Poorly Differentiated 
Transitional Cell Carcinoma 
'Il·ansitional Cell Carcinoma 
Transitional Cell Carcinoma, Papillary 
Transitional Cell Carcinoma 
Transitional Cell Carcinoma, Papillary, Poo~·ly Differentiated 
Transitional Cell Carcinoma 
Melanoma, Poorly Differentiated 
Melanoma 
Melanoma 
Melanoma 
Melanoma 
Ivielanoma 
Melanoma 
Melanoma 
Adenocarcinoma, Moderately to Poorly Differentiated 
Adenocarcinoma 
Leukemia 
Renal 
Pancreas 
3663 
2967 
5116 
3226 
4915 
25.52 
AML (1,PK) BM 
AML (2,PK) BM 
AML (3,PK) BM 
AML (.5,PK) BM 
AML (6,PK) BM 
AML (7,PK) BM 
AML (12,PK) BM 
AML (13,PK) BM 
ALL (16415) BM 
ALL (19881) BM 
ALL (9186) BM 
ALL (9723) BM 
ALL (17269) BM 
ALL(14402) BM 
ALL (17638) BM 
ALL (22474) BM 
ALL (19769) BM 
ALL (23953) BM 
ALL (28373) BM 
ALL (933.5) BM 
ALL (9692) BM 
ALL (14749) BM 
ALL (17281) BM 
ALL (19183) BM 
92 I 126 
Carc_609TO 
Carc_628TG 
Carc_614TS 
Carc_614TO 
Carc_623TS 
Carc_623TO 
5291 
9.5 I 298 (I) 
Pan lT 
Pan 2T 
Pan 3T 
Pan4T 
Pan 6T 
Pan 7T 
3.5 
Adenocarcinoma 
Adenocarcinoma 
Adenocarcinoma 
Adenocarcinoma 
Adenocarcinoma 
Adenocarcinoma 
Leukemia, Acute Myelogenous 
Leul~emia, Acute Myelogenous 
Leukemia, Acute Myelogenous 
Leukemia, Acute Myelogenous 
Leukemia, Acute Myelogenous 
Leukemia, Acute Myelogenous 
L~ukemia, Acute Myelogenous 
Leukemia, Acute Myelogenous 
Leukemia, Acute Lymphocyitc, T-cell 
Leukemia, Acute Lymphocyitc, T-cell 
Leukemia, Acute Lymphocyitc, T-cell 
Leukemia, Acute Lymphocyitc, T-cell 
Leukemia, Acute Lymphocyitc, T-cell 
Leukemia, Acute Lymphocyitc, T-cell 
Leukemia, Acute LympJ:!ocyitc, T-cell 
Leukemia, Acute Lymphocyitc, T-cell 
Leukemia, Acute Lymphocyitc, B-cell 
Leukemia, Acute Lymphocyitc, B-cell 
Leukemia, Acute Lymphocyitc, B-cell 
Leukemia, Acute Lymphocyitc, B-cell 
Leukemia, Acute Lymphocyitc, B-cell 
Leukemia, Acute Lymphocyitc, B-cell 
Leukemia, Acute Lymphocyitc, B-cell 
Leukemia, Acute Lymphocyitc, B-cell 
Renal Cell Carcinoma, Moderately to Poorly Differentiated 
Renal Cell Carcinoma 
Renal Cell Carcinoma 
Renal Cell Carcinoma 
Renal Cell Carcinoma, Moderately to Poorly Differentiated 
Renal Cell Carcinoma 
Renal Cell Carcinoma 
Renal Cell Carcinoma 
Adenocarcinoma, Moderately Differentiated 
Adenocarcinoma, Poorly Differentiated 
Adenocarcinoma 
Adenocarcinoma 
Adenocarcinoma 
Adenocarcinoma 
Adenocarcinoma 
Pan 16T 
Ovary mOVT1 (8691) 
mOVT2 (I) (9334) 
93 I 081 
HCTN 19155 
HCTN 0002c011N 
07-B OOlB 
07-B 014G 
H (400)6346 
Mesothelioma 161 T6 
31 TlO 
169 T7 
Hm·T.s 
228 T4 
235 T6 
74 T6 
215 T5 
CNS GlioB_1 
GlioB_2 
GlioB_3 
GlioBA 
GlioB_.s 
GlioB_6 
GlioB_7 
GlioB_s 
M29_A91 
M22_A50 
M42_Al0 
M20...A56 
M49...A2 
M06..D92 
M02..D16 
M50..D7 
A.2 Test Sa1nples 
Class Sample Name 
Breast 93 I 192 
89-B 005A 
09-B 003A 
Prostate 95 I 256 
p 0062 
Lung H 20154 
LT14 
36 
Adenocarcinoma 
Adenocarcinoma, Mixed Serous and Transitional 
Adenocarcinoma, Serous Papillary, Poorly Differentiated 
Adenocarcinoma 
Adenocarcinoma, Endometr'oid 
Adenocarcinoma, Serous Papillary 
Adenocarcinoma, Papillary, Poorly Differentiated 
Adenocarcinoma, Serous Papillary 
Adenoc.arcinoma, Clear Cell 
Mesothelioma, Pleural 
Mesothelioma, Pleural 
Mesothelioma, Pleural 
Mesothelioma, Pleural 
Mesothelioma, Pleural 
Mesothelioma, Pleural 
Mesothelioma, Pleural 
Mesothelioma, Pleural 
Glioblastoma 
Gliobl<).Stoma 
Glioblastoina 
Glioblastoma 
Glioblastoma 
Glioblastoma 
Glioblastoma 
Glioblastoma 
Medulloblastoma 
Medulloblastoma 
Medulloblastoma 
Medulloblastoma 
Medulloblastoma 
Medulloblastoma 
Medulloblastoma 
Medulloblastoma 
Pathology 
Adenocarcinoma 
Adenocarcinoma, Infiltrating Ductal, Moderately Differentiated 
Adenocarcinoma, Invasive Ductal 
Adenocarcinoma 
Adenocarcinoma, Poorly Differentiated 
Adenocarcinoma, Moderately Differentiated 
Adenocarcinoma 
Colo rectal 
Lymphmna 
Bladder 
Melanoma 
Uteri.1s 
Leukemia 
Renal 
Pancreas 
Ovary 
Mesothelioma 
CNS 
Ovary 
Colorectal 
Lung 
Prostate 
Prostate 
Prostate 
9.5 I 117 
HCTN 19389 
0001c026 CC 
9.5 I 175 
L_B_CELL_S94_6696_G 
L_B_CELLS97 _27534_G 
L_B_CELL_S98_1217 _R 
FSCC_S93_11021 
FSCC_S99_9100 
FSCC_S99_5073_1 
B_0007 
B_0008 
104-64931 
MGH 8907 
MGH 7974 
4075 
4840 
AML (14,PK) BM 
AML (16,PK) BM 
ALL (92_.571) ~M 
ALL (87 _52) BM 
ALL (20414) BM 
ALL (21302) BM 
6775 
5382 
6727 
Pan 29T 
Pan 17T 
97 I 077 
0001c086 
H .6206 
HCTN 19120 
166 T4 
224 T.5 
300 T 
GlioB_9 
GlioB_10 
M5LD34 
M33 
9912c062cc_Rb 
HCTN 19274 
H 20300 
.MetCaP1 
MetCaP109 
MetCaP12.5 
37 
Adenocarcinoma, Moderately to Poorly Differentiated 
Adenocarcinoma 
Adenocarcinoma 
Adenocarcinoma, Moderately Differentiated 
Lymphoma, Large B-cell 
Lymphoma, Large B-cell 
Lymphoma, Large B-cell 
Lymphoma, Follicular 
Lymphoma, Follicular 
Lymphoma, Follicular 
Transitional Cell Carcinoma, Moderately to Poorly Differentiated 
Transitional Cell Carcinoma. 
Transitional Cell Carcinoma 
Melanoma 
Melanoma 
Adenocarcinoma 
Adenocarcinoma 
Leukemia, Acute Myelogenous 
Leukemia, Acute Myelogenous 
Leukemia, Acute Lymphocytic, T-cell 
Leukemia, Acute Lymphocytic, T-cell 
Leukemia, Acute Lymphocytic, B-cell 
Leukemia, Acute Lymphocytic, B-cell 
Renal Cell Carcinoma 
Renal Cell Carcinoma 
Renal Cell Carcinoma 
Adenocarcinoma 
Adenocarcinoma 
Adenocarcinoma 
Adenocarcinoma, Papillary Serous, Poorly Differentiated 
Adenocarcinoma, Endometrioid 
Adenocarcinoma, Papillary Serous, Poorly Differentiated 
Mesothelioma, Pleural 
Mesothelioma, Pleural 
:t•iesothelioma, Pleural 
Glioblastoma 
Glioblastoma 
Medulloblastoma 
Medulloblastoma 
Metastases to Peritoneum, Adenocarcinoma 
Metastases to Liver, Adenocarcinoma, Moderately Differentiated 
l\fetastases to Liver, Adenocarcinoma 
Metastases to Bone, Adenocarcinoma 
Metastases to Bone, Adenocarcinoma 
Metastases to Bone, Adenocarcinoma 
Prostate 
Breast 
MetCaP128 
MGHA934 
38 
Metastases to Bone, Adenocarcinoma 
Metastases to Lymph Node 
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